Stock C4X VALERIO THERAPEUTICS
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Valerio Therapeutics Deutsche Boerse AG

Equities

C4X

FR0010095596

Delayed Deutsche Boerse AG
Other stock markets
 03:17:49 2024-07-05 EDT 		5-day change 1st Jan Change
0.09 EUR -13.46% Intraday chart for Valerio Therapeutics -10.00% -40.59%
05-22 Valerio Therapeutics S.A. Provides Clinical Development Update on Its Phase 1/2 VIO-01 Clinical Trial CI
04-30 Valerio Therapeutics Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Evolution of the average Target Price on Valerio Therapeutics

Price target over the last 5 years

History of analyst recommendation changes

1b4b22a7cb3.Cn3UeCtAdqVPe3s4JsnYijb-OZK-NS_f15DoJqAA3F8.eT7gCmVxIcw5Kh9oUvGS-VqtacPPVGeNmKGHFeZEly1OMLM_bgks6yEhQw~573b5ff36f6a211e13d9702ed12b62ad

Analyst Recommendations on Valerio Therapeutics

Onxeo : Bryan Garnier & Co initiates the coverage of Onxeo with a “Buy” recommendation PU
Bryan Garnier & Co Initiates Coverage of Onxeo with a “Buy” Recommendation GL
Onxeo : Bryan Garnier & Co Initiates the Coverage of Onxeo with a “Buy” Recommendation BU
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.105 EUR
Average target price
1.2 EUR
Spread / Average Target
+1,042.86%
High Price Target
1.2 EUR
Spread / Highest target
+1,042.86%
Low Price Target
1.2 EUR
Spread / Lowest Target
+1,042.86%

Consensus detail

Consensus revision (last 18 months)

Annual profits - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. ALVIO Stock
  4. C4X Stock
  5. Consensus Valerio Therapeutics